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Administrative, anthropometric, laboratory (test code, test collection date, test result values, and abnormal flag), clinical diagnosis, and medication data collected at these facilities are available in electronic form for both inpatients and outpatients from 1997. Using these data, we have established the LSUHLS. 14 mg/dl. 25 The first record of diabetes diagnosis was used to establish the baseline for each patient in the present analyses due to the design of the cohort study. Before diagnosis with diabetes, these patients have used our system for an average of 5.0 years. We have validated the diabetes diagnosis in LSUHCSD hospitals. The agreement of diabetes diagnosis was 97%: 20,919 of a sample of 21,566 hospital discharge diagnoses based on ICD codes also had physician-confirmed diabetes using the ADA diabetes diagnosis criteria. 25 After excluding patients with incomplete data of BMI measurement (N=19,201), smoking information (N=12,309), treatment information (N=12,219), and other required variables for analysis (all variables listed in Table 1 ) (N=1488), and the patients with only one BMI measurement (N=84), the present study included 34,832 patients with type 2 diabetes (15, 354 white and 19,478 African American) who were 30 to 94 years of age with complete repeated data on all risk factor variables. Patients were excluded if they were underweight (BMI <18. 5) because these patients may have other comorbidities. In these 34,832 patients with diabetes, olerance test (OGTT); one or more classic symptoms plus a random plasma gluc uc cos s se e e le le leve e vel l l 20 2 200 mg/dl. 25 The first record of diabetes diagnosis was used to establish the baseline for each patient n n t the he he p p pre rese se sent nt nt ana na aly ly lys ses due to the design of the co co coho ort study. Befo fo ore r d di iag ag agn nosis with diabetes, System. We did not obtain informed consent from participants involved in our study because we used anonymized data compiled from electronic medical records. 
Baseline and follow-up measurements

Statistical analyses
The association between BMI and all-cause mortality was analyzed by using Cox proportional hazards models. BMI was evaluated in the following 2 ways: (1) as 6 categories (BMI <23, 23-24.9, 25-29.9, 30-34.9 [reference group], 35-39.9, and 40 kg/m 2 ), and (2) as a continuous
The last value of BMI was the last measurement of BMI before death occurred, o o or b b bef ef for o ore e e th th the e e en e d of follow-up (June 30, 2013). The average number of BMI measurements during the follow-up pe eri ri iod od od w w was as as 1 1 15 5 5.0 (m (m (med e ian 11; interquartile range 5 5-5-2 2 21).
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Fo Foll ll llow ow w-u -up p p in in inf fo form rm ma at atio ion n n w wa was o ob obta ta tain in ined ed ed f fr ro rom m m th th the e LS LS L H UH UHL LS LS i i inp np npat at tie ie ien n nt a a and nd n o o ou ut utpa pa ati ti t en en ent t da da dat t taba ba ase se e b by y y using the uniq iq ique ue ue n n num um umbe be ber r as as assi si ign gn gned ed ed t to o o ev v ver er ery y y pa pa pati ti tien en ent t wh wh w o o vi vi v si si sits ts ts t t the he he L L LSU SU SUHC HC HCSD SD SD h h hos os ospi pi pita ta tals ls. The 26 The proportional hazards assumption in the Cox model was assessed with graphical methods, and with models including time-bycovariate interactions. 27 In general, all proportionality assumptions were appropriate. All analyses were adjusted for age and sex, and further for smoking, income, and type of insurance.
We stratified the samples by race because there was a significant interaction between race and BMI on all-cause mortality. To avoid the potential bias due to occult disease at baseline, additional analyses were carried out excluding the subjects who died during the first two years of follow-up. We used the restricted cubic spline nested in time-dependent Cox models to test whether there is a dose-response or non-linear association of BMI as a continuous variable with all-cause mortality risk. 28 Statistical significance was considered to be P<0.05. All statistical analyses were performed with PASW for Windows, version 20.0 (IBM SPSS Inc, Chicago, III) and SAS for Windows, version 9.3 (SAS Institute, Cary, NC).
Results
General characteristics of the study population are presented by race in Table 1 (Online table 4 ).
Discussion
Our study found a U-shaped association of BMI with all-cause mortality risk among African Only a few prospective studies have evaluated the association between BMI and total mortality among patients with diabetes, and the results are controversial. Some studies provide supportive information of an "obesity paradox" which describes the inverse association between excess adiposity as defined by BMI and mortality, [3] [4] [5] [6] [7] other studies have reported positive associations, 8, 9 U-shaped associations, [10] [11] [12] or no association 13 between BMI and mortality among patients with diabetes. The recently published results from the Look AHEAD (Action for Health in Diabetes) 29 have shown that an intensive lifestyle intervention focusing on weight loss did not reduce the rate of cardiovascular events in overweight or obese adults with type 2 diabetes. In the present study, our data showed a significantly increased risk of all-cause mortality among both African American and white patients with type 2 diabetes in the high BMI group and the low BMI group as well. The most benefit for all-cause mortality risk associated with BMI was among African Americans with BMI 30-34.9 kg/m 2 and among whites with BMI 25-39.9 kg/m 2 . We found this U-shaped association of all-cause mortality risk by BMI at baseline as well as during 34.9 kg/m 2 .
Only a few prospective studies have evaluated the association between BMI and total mo mort rt rtal al alit it ity y am am amo o ong g p pa pati t ents with diabetes, and the re re resu ults are contro ove v v rs sia ia al l. l. Some studies provide u upp p pportive inf for orma ma mati io on n o o of f f an an an " "ob obe es esit it ity y pa pa arad do ox x x" w w wh hi ich h d de desc sc cri ibe bes s th h he e in inve ve vers se e e a as asso soci ci c at at atio ion n n be be betw tw we e een ex xce ce cess ss ss a adi dipo po posi sity ty y as s s de def fin ne ned d by by by B B BMI MI MI a an nd nd m m mor or orta a ali li lity ty y, 3 Potential methodological concerns should be considered when assessing the associations between obesity and health outcomes. 30 The most serious concern is reverse causation associated with total mortality. People with a history of CVD or cancer frequently lose weight and thus people with a lower weight might increase the estimated risk death. When we excluded patients with a history of coronary heart disease and cancer which can minimize the influence of reverse causation, the U-shaped association did not change. Moreover, we performed another sensitivity analysis by excluding the subjects who died during the first two years of follow-up, and the Ushaped association was still present. Another major concern is the adequate control for confounding factors and potentially over-adjusting for the physiologic effects of excess fatness, such as hypertension, diabetes, and dyslipidemia, which were controlled statistically, thus artificially removing some of the effects of being overweight. All three of these concerns were statistically controlled for in our study. Further when we restrict the analysis to subjects who have never smoked, the results did not change. Our result is different from a recent published paper which showed a direct linear relationship between BMI and mortality among those who had never smoked. 12 Potential explanations of this U-shaped association among patients with diabetes are unclear. For the negative part of the curve, the increased risk of death associated with a low BMI, some investigators have suggested that patients with low-normal weight are associated with a clinical sign of insufficient insulin secretion which could potentially lead to faster progression of nephropathy and subsequently, increased mortality. 10 For the positive part of the curve, the increased risk of death associated with a high BMI, many previous studies among patients with haped association was still present. Another major concern is the adequate cont ntr r rol l fo for r confounding factors and potentially over-adjusting for the physiologic effects of excess fatness, u uch ch h a a as s s hy hy hype pe p r r rten n nsi si sio on on, diabetes, and dyslipidemia a a, , w w which were con n ntr t when the analysis was focused on those who are extreme obese, like BMI 40 kg/m 2 . There is substantial evidence supporting the biologic plausibility of a U-shaped association between adiposity and the risk of death in the general population, and a recently published meta-analysis showed the same U-shaped association as our study. 31 Obesity is a well-established risk factor for numerous chronic diseases 32 and adipose tissue can release a large number of cytokines and bioactive mediators which play important roles in the pathogenesis of many obesity related cardiovascular diseases. 33 There are several strengths in our study, including the large sample size, long follow-up time, and the use of administrative databases to avoid differential recall bias. We have used baseline BMI levels or BMI values as time-dependent variables in Cox models, which can avoid potential bias from a single baseline measurement. In addition, participants in this study use the same public health care system which minimizes the influence from the accessibility to health care. The reliance on direct assessments of BMI rather than self-reported values are also marked strengths of this study. One limitation of our study is that our analysis was not performed on a representative sample of the population which limits the generalizability of this study; however, LSUHCSD hospitals are public hospitals and cover over 1.6 million patients most of whom are low income persons in Louisiana. The results of the present study will have wide applicability for the population with low income and without health insurance in the US. Second, more than 45,000 patients with diabetes were excluded in the present study due to missing data on one or more of the required variables, and these patients were younger, had less African Americans, and less males compared with the patients with type 2 diabetes included in the present study.
Excluding these patients might have a possible selection bias. Third, we did not have information ime, and the use of administrative databases to avoid differential recall bias. We We h hav av a e e us us used ed ed . 17 ed for age, sex, race, type of insurance, income, and smoking at baseline (in the baseline analyses), during follow-up (in the follow-up analyses) and n the last visit analyses), other than the variable for stratification. 
